With regard to down-regulated genes involved in angiogenesis within the canonical HIF-1 signaling pathway, angiopoietin 1 (ANGPT1)—a putatively favorable serum prognostic marker for non-small cell lung cancer [58]—had suppressed expression across LUAD tumor at stages 1–4. This evidence concerns the gene ANGPT1 and neoplasm.